GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 89 filers reported holding GALENA BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $26,000 | -64.4% | 55,646 | +4.4% | 0.00% | – |
| Q1 2016 | $73,000 | +35.2% | 53,301 | +44.6% | 0.00% | – |
| Q4 2015 | $54,000 | -3.6% | 36,854 | +3.6% | 0.00% | – |
| Q3 2015 | $56,000 | -9.7% | 35,588 | -2.1% | 0.00% | – |
| Q2 2015 | $62,000 | +29.2% | 36,362 | +5.3% | 0.00% | – |
| Q1 2015 | $48,000 | 0.0% | 34,525 | +8.1% | 0.00% | – |
| Q4 2014 | $48,000 | 0.0% | 31,925 | +35.1% | 0.00% | – |
| Q3 2014 | $48,000 | -72.9% | 23,626 | -59.0% | 0.00% | – |
| Q2 2014 | $177,000 | +19.6% | 57,620 | -3.0% | 0.00% | – |
| Q1 2014 | $148,000 | -37.8% | 59,425 | +23.7% | 0.00% | -100.0% |
| Q4 2013 | $238,000 | +126.7% | 48,032 | +4.6% | 0.00% | – |
| Q3 2013 | $105,000 | +34.6% | 45,904 | +31.8% | 0.00% | – |
| Q2 2013 | $78,000 | – | 34,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harbour Capital Advisors, LLC | 114,350 | $236,000 | 0.20% |
| Thomasville National Bank | 95,000 | $195,000 | 0.08% |
| SMITH ASSET MANAGEMENT GROUP LP | 552,160 | $1,137,000 | 0.04% |
| KMS FINANCIAL SERVICES, INC | 118,042 | $243,000 | 0.03% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $61,000 | 0.03% |
| Alyeska Investment Group, L.P. | 530,000 | $1,092,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 282,704 | $582,000 | 0.02% |
| PIPER SANDLER & CO. | 20,000 | $41,000 | 0.02% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $31,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 539,031 | $1,110,000 | 0.02% |